跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CABAZITAXEL FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CABAZITAXEL FOR INJECTION
Authorized
STANDARD
CABAZITAXEL FOR INJECTION
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
596f5b4bf4a2d55b
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
596f5b4bf4a2d55b
Drug Approval Canada Name
CABAZITAXEL FOR INJECTION
Product Name
CABAZITAXEL FOR INJECTION
Status
Marketed
Status Date
2019-12-18
Original Market Date
2019-12-18
Din
02487500
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01CD04 CABAZITAXEL
Atc Name
l 01 cd 04
Aig Number
0152936002
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
CABAZITAXEL
60 MG / 6 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
596f5b4bf4a2d55b
Type
Standard
Back to Health Canada Approvals